FDA Inspection 1317176 — Personal Genome Diagnostics Inc.
The FDA completed an inspection of Personal Genome Diagnostics Inc. on April 17, 2026 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Project Evaluation: Devices
- Location
- Baltimore, MD (United States)